By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management
Overview
These updated guidelines from the Society of Obstetricians and Gynaecologists of Canada present the current evidence to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: May 1, 2022
Contact: practice@apta.org
Content Type: CPG
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group
You Might Also Like...
CPG
ESC/ERS 2022 Guidelines for the Diagnosis and Treatment of Pulmonary HypertensionOct 7, 2022
Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory
CPG
APTA Pelvic Health: Clinical Practice Guidelines for Pelvic Girdle Pain in the Postpartum Population (CPG+)Jan 1, 2022
This clinical guideline describes evidence-based physical therapist practice, including screening, diagnosis, prognosis, intervention, and assessment of
CPG
Guideline-Driven Management of Hypertension: An Evidence-Based UpdateApr 1, 2021
This report takes a rigorous, evidence-based approach to recommend treatment thresholds, goals, and medications in the management of hypertension in